RNA — ATRIUM THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 159 家机构在其最新 13F 申报中持有 RNA(ATRIUM THERAPEUTICS INC),合计申报市值 $213.97M,对应 17.38M 股。按股数计算较上季度增持 15.9%(+2.05M 股),申报市值环比上升 19.5%。持仓集中度较高:前五大持有人占申报市值的 37.7%,前十大的集中度为 52.3%。
与上一季度相比,42 家新建仓位、48 家加仓、36 家减仓、48 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ATRIUM THERAPEUTICS INC(RNA)的主要机构持有人包括 Wellington Management Group、Vanguard Group、Sessa Capital IM, L.P.,按 13F 申报市值在本页 228 家持有人中排名居前。
RNA 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 94 | 5.79M | $47.96M | +10.7% |
| Q2 2026 | 159 | 17.38M | $213.97M | +15.9% |
| Q1 2026 | 165 | 16.91M | $205.39M | -50.9% |
| Q4 2025 | 9 | 4.57M | $318.14M | -78.7% |
| Q3 2025 | 7 | 21.03M | $490.15M | -2.6% |
| Q2 2025 | 8 | 21.60M | $306.74M | -3.2% |
| Q1 2025 | 7 | 22.09M | $317.76M | +9.3% |
| Q4 2024 | 9 | 20.84M | $283.89M | +4.9% |
表内 8 个季度中,机构持股合计减少 72%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(-78.7%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.22M | $10.09M | 0.00% | 减持 | |
| 730.03K | $6.04M | 0.00% | 持有 | |
| 379.82K | $3.15M | 0.00% | 减持 | |
| 321.49K | $2.66M | 0.01% | 增持 | |
| 311.72K | $2.58M | 1.14% | 增持 | |
| 291.02K | $2.41M | 0.00% | 增持 | |
| 200.00K | $1.66M | 0.14% | 增持 | |
| 178.82K | $1.48M | 0.00% | 增持 | |
| 178.32K | $1.48M | 0.42% | 增持 | |
| 150.00K | $1.24M | 0.12% | 增持 | |
| 116.27K | $962.74K | 0.01% | 增持 | |
| 113.72K | $941.63K | 0.09% | 增持 | |
| 112.65K | $932.76K | 0.70% | 新进 | |
| 112.53K | $931.79K | 0.00% | 减持 | |
| 110.24K | $912.79K | 0.00% | 持有 | |
| 107.97K | $894.00K | 0.51% | 持有 | |
| 106.53K | $882.09K | 0.00% | 新进 | |
| 102.95K | $852.47K | 0.00% | 增持 | |
| 80.11K | $663.33K | 0.00% | 增持 | |
| 63.75K | $527.87K | 0.00% | 减持 | |
| 61.26K | $507.19K | 0.01% | 增持 | |
| 59.33K | $491.23K | 0.00% | 新进 | |
| 58.38K | $483.40K | 0.61% | 减持 | |
| 55.89K | $462.79K | 0.00% | 增持 | |
| 44.23K | $366.22K | 0.01% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 9 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 2.42M | $174.21M | 0.08% | 增持 | |
| 1.18M | $85.23M | 0.01% | 增持 | |
| 723.12K | $52.16M | 0.01% | 减持 | |
| 71.63K | $5.17M | 0.02% | 新进 | |
| 14.15K | $1.02M | 0.00% | 新进 | |
| 13.90K | $181.95K | 0.00% | 增持 | |
| 1.77K | $128.03K | 0.07% | 持有 | |
| 2.10K | $27.49K | 0.00% | 新进 | |
| 142.89K | $10.31K | 0.00% | 减持 |
Q3 2025 — 7 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 10.07M | $438.54M | 0.08% | 增持 | |
| 1.12M | $48.96M | 0.01% | 增持 | |
| 37.52K | $1.63M | 0.00% | 减持 | |
| 11.58K | $504.41K | 0.00% | 减持 | |
| 9.79M | $426.44K | 0.05% | 减持 | |
| 1.77K | $77.34K | 0.05% | 持有 | |
| 1.00K | $7.28K | 0.00% | 增持 |
Q2 2025 — 8 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.25M | $262.69M | 0.05% | 减持 | |
| 1.05M | $29.77M | 0.01% | 增持 | |
| 251.99K | $7.16M | 0.00% | 增持 | |
| 237.40K | $6.74M | 0.01% | 新进 | |
| 10.81M | $306.97K | 0.04% | 减持 | |
| 1.77K | $50.41K | 0.03% | 持有 | |
| 4.80K | $25.00K | 0.00% | 增持 | |
| 100 | $536 | 0.00% | 新进 |
新建仓(Q2 2026)
- CRCM LP 641.54K 股 · $8.63M
- GEODE CAPITAL MANAGEMENT, LLC 386.93K 股 · $5.21M
- AQR Capital Management 172.24K 股 · $2.32M
- AQR CAPITAL MANAGEMENT LLC 172.24K 股 · $2.32M
- Sixth Street Partners Management Company, L.P. 130.22K 股 · $1.75M
- DAFNA Capital Management LLC 128.00K 股 · $1.72M
- Norges Bank Investment Management 126.58K 股 · $1.70M
- Anson Funds Management LP 125.00K 股 · $1.68M
- Trium Capital LLP 113.28K 股 · $1.52M
- BlueCrest Capital Management Ltd 100.00K 股 · $1.34M
- Franklin Resources 56.70K 股 · $762.60K
- JACOBS LEVY EQUITY MANAGEMENT, INC 53.99K 股 · $726.19K
完全清仓(较上季)
- RA CAPITAL MANAGEMENT, L.P. 卖出 864.10K 股 · $11.55M
- Pentwater Capital Management LP 卖出 602.65K 股 · $8.06M
- O'Connor Alternative Investments LLC 卖出 578.01K 股 · $7.73M
- Farallon Capital Management 卖出 349.36K 股 · $4.67M
- FARALLON CAPITAL MANAGEMENT, L.L.C. 卖出 349.36K 股 · $4.67M
- Bellevue Group AG 卖出 263.10K 股 · $3.52M
- STATE STREET CORP 卖出 257.09K 股 · $3.44M
- AQR Arbitrage LLC 卖出 179.71K 股 · $2.40M
- Janus Henderson Group 卖出 139.97K 股 · $1.87M
- Neuberger Berman Group LLC 卖出 69.29K 股 · $926.46K
- Quarry LP 卖出 66.65K 股 · $891.12K
- Westchester Capital Management, LLC 卖出 55.24K 股 · $738.51K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 1.22M | 1.45M | 1.21M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 730.03K | 730.83K | 626.87K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 379.82K | 386.93K | 319.83K | — | — | — | — | — | — | — | — | — | — | 1.44M | 1.30M | — | 939.62K | 848.70K | 737.10K | 714.24K |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 321.49K | 31.48K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Arbiter Partners Capital Management LLC | 311.72K | 261.29K | 230.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 291.02K | — | 257.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlueCrest Capital Management Ltd | 200.00K | 100.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Quantinno Capital Management LP | 178.82K | 27.42K | 12.45K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Yakira Capital Management, Inc. | 178.32K | 133.05K | 126.64K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AWM Investment Company, Inc. | 150.00K | 107.50K | 50.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Groupe la Francaise | 116.27K | 80.27K | 29.70K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CREDIT INDUSTRIEL ET COMMERCIAL | 113.72K | 89.72K | 23.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kalehua Capital Management LLC | 112.65K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 112.53K | 146.74K | 231.47K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 110.24K | 109.96K | 95.13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Athos Capital Ltd | 107.97K | 107.97K | 107.97K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 106.53K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 102.95K | 101.19K | 344.37K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 80.11K | 41.94K | 165.04K | — | — | — | — | — | — | — | — | — | — | 1.10M | 1.25M | 1.02M | 80.58K | 134.23K | 109.37K | 74.82K |
| JANE STREET GROUP, LLC | 63.75K | 109.81K | 19.95K | — | — | — | — | — | — | 15.00K | 81.80K | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold RNA?
As of 2026-Q2, 159 institutional funds reported holding RNA (ATRIUM THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $213.97M.
How many shares of RNA do institutions own?
13F filers reported 17.38M shares of RNA, worth $213.97M in aggregate at the end of 2026-Q2.
Is institutional ownership of RNA rising or falling?
Share counts moved +15.9% versus the prior quarter — accumulation.
Who are the top institutional holders of RNA?
The largest 13F holders are Wellington Management Group, Vanguard Group, Sessa Capital IM, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Alkeon Capital Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of ATRIUM THERAPEUTICS INC?
The major shareholders of ATRIUM THERAPEUTICS INC (RNA) by reported 13F value are Wellington Management Group, Vanguard Group, Sessa Capital IM, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Alkeon Capital Management, among 228 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.